Suchergebnisse - "Disel, Umut"

PubPharm (91)

1

Increased KRAS G12C Prevalence, High Tumor Mutational Burden, and Specific Mutational Signatures Are Associated With MUTYH Mutations : A Pan-Cancer Analysis

enthalten in: The oncologist | 2024

von Disel, U. | Sivakumar, S. | Pham, T. | +4

2

The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors : A Turkish oncology group ( TOG) study

enthalten in: Cancer Medicine | 2024

von Guven, D. | Aykan, M. | Muglu, H. | +16

3

The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors : A Turkish oncology group (TOG) study

enthalten in: Cancer medicine | 2023

von Guven, D. | Aykan, M. | Muglu, H. | +16

4

Tislelizumab Versus Docetaxel in Patients With Previously Treated Advanced NSCLC (RATIONALE-303) : A Phase 3, Open-Label, Randomized Controlled Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Zhou, C. | Huang, D. | Fan, Y. | +19

CommentIn: J Thorac Oncol. 2023 Jan;18(1):17-20. - PMID 36543431

5

Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations : A real-life data of Turkish Oncology Group

enthalten in: Medicine | 2022

von Gürbüz, M. | Kiliçkap, S. | Bilici, A. | +23

6

Epidermal Growth Factor Receptor Inhibition in Epidermal Growth Factor Receptor-Amplified Gastroesophageal Cancer : Retrospective Global Experience

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Maron, S. | Moya, S. | Morano, F. | +27

7

The Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA

enthalten in: The oncologist | 2020

von Disel, U. | Madison, R. | Abhishek, K. | +31

8

The Pan‐Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA

enthalten in: The oncologist | 2020

von Disel, U. | Madison, R. | Abhishek, K. | +31

9

Durable clinical benefit to trastuzumab and chemotherapy in a patient with metastatic colon adenocarcinoma harboring ERBB2 amplification

enthalten in: Oncoscience | 2015

von Disel, U. | Germain, A. | Yilmazel, B. | +12

10

Can serial monitoring of serum Vascular Endothelial Growth Factor (VEGF), Nitric Oxide (NO), and Angiotensin II (ANGII) levels have predictive role during Bevacizumab treatment?

enthalten in: Medical science monitor : international medical journal of experimental and clinical research | 2014

von Sümbül, A. | Dişel, U. | Sezgin, N. | +6

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]